Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.
포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.
터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
BioSenic fait le point sur ses activités du troisième trimestre 2024 BioSenic fait le point sur ses activités du troisième trimestre 2024 BioSenic...
BioSenic provides third quarter 2024 Business Update BioSenic provides third quarter 2024 Business Update BioSenic is actively seeking one or more...
BioSenic S.A. : Notification de transparence reçue de la part de ABO Infinium Americas OpCo LTD. INFORMATION REGLEMENTEE Article 14 de la loi...
BioSenic S.A. : Transparency notification received from ABO Infinium Americas OpCo LTD. REGULATED INFORMATION Article 14 of the Law of 2 May...
BioSenic annonce démarrer la recherche de nouveaux actifs, la sécurisation de son financement pour les prochains mois par le biais d'un...
BioSenic announces that it has started to look for new assets, the securing of its financing for the coming months by means of an amendment to its...
BioSenic reports half year 2024 results REGULATED INFORMATIONThe interim financial report is prepared in accordance with article 13 of the Royal...
BioSenic publie ses résultats pour le premier semestre 2024 INFORMATION REGLEMENTEELe rapport semestriel est préparé conformément à l’article 13...
Véronique Pomi-Schneiter stands down as BioSenic's Deputy CEO PRIVILEGED INFORMATION Mont-Saint-Guibert, Belgium, September 17, 2024 7.00pm...
Véronique Pomi-Schneiter démissionne de ses fonctions de Directrice Générale Adjointe de BioSenic INFORMATION PRIVILIGIEE Mont-Saint-Guibert...
BioSenic S.A.: Transparency notification received from ABO Infinium Americas OpCo LTD. REGULATED INFORMATION Article 14 of the Law of 2 May...
BioSenic S.A. : Notification de transparence reçue de la part de ABO Infinium Americas OpCo LTD. INFORMATION REGLEMENTEE Article 14 de la loi du...
Medsenic receives the intention to grant a key European patent from EPO, valuable for the therapeutic development of arsenic trioxide in...
Medsenic reçoit l'intention de délivrer un brevet européen clé de l'OEB, précieux pour le développement thérapeutique du trioxyde...
Medsenic/BioSenic patent granted in Japan for more protection of its therapeutic platform PRIVILEGED INFORMATION Composition-of-matter patent...
귀하가 조회한 주식이 이 박스에 나타나며 쉽게 최근 시세로 돌아갈 수 있습니다.
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관
광고 없는 경험을 위해 가입하세요
지금 사용해 보세요
광고 유지